SCHEMBL9868525

SCHEMBL9868525

NC(=NCCSCc1ccc(Cl)cc1)NCCCc1c[nH]cn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.44
HRH2 P25021 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
LMNA P02545 3/20 0.36
HPGD P15428 2/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866042 0.90 SCN5A (0.44) SIGMAR1HRH2HRH4HRH3LMNA
SCHEMBL10371006 0.89 ALDH1A1 (0.41) SIGMAR1HRH4HRH3HPGDALDH1A1
SCHEMBL9876542 0.89 HRH4 (0.39) SIGMAR1HRH2HRH4HRH3CYP1A2
SCHEMBL9865263 0.88 LMNA (0.41) HRH2HRH4HRH3LMNAALDH1A1
SCHEMBL7178167 0.87 HRH4 (0.41) SIGMAR1HRH2HRH4HRH3
SCHEMBL9867274 0.85 MC3R (0.37) SIGMAR1HRH2HRH4HRH3LMNA
SCHEMBL9171834 0.83 HRH4 (0.41) SIGMAR1HRH2HRH4HRH3
SCHEMBL7175112 0.83 HRH2 (0.38) SIGMAR1HRH2HRH4HRH3
SCHEMBL9868517 0.82 KMT2A (0.42) LMNAHPGDUSP2POLBALDH1A1
SCHEMBL7180743 0.82 HRH2 (0.37) SIGMAR1HRH2HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed